Litigation

Recent Posts

High Court: Investors Properly Pleaded Materiality In Securities Class Action Suit
Posted on 23 Mar 2011 by Timothy Raub

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on March 22 unanimously affirmed that shareholders of a drug maker properly showed that the drug maker violated federal securities law by failing to disclose that one of its products caused adverse... Read More

Tags: Supreme Court , Securities Law , Zicam , drug maker , Matrixx Initiatives , Litigation , lawsuit , Matrixx Initiatives v. James Siracusano , Securities Exchange Act , Basic Inc. v. Levinson , Securities

Sanofi Loses Cancer Drug Patent Fight In Delaware
Posted on 28 Sep 2010 by LexisNexis Litigation Resource Community Staff

WILMINGTON, Del. - (AP) A federal judge in Delaware has ruled against French drug maker Sanofi-Aventis SA in a patent dispute involving its cancer drug Taxotere. Full version available to lexis.com subscribers . Read More

Tags: drug maker , breast cancer , cancer drug , Patent , prostate cancer , Apotex Corp. , Litigation , Taxotere , lawsuit , Hospira Inc. , Sanofi-Aventis

Glaxo Settles Bad Drug Claim For More Than $40 Million
Posted on 24 Jun 2011 by LexisNexis Litigation Resource Community Staff

PROVIDENCE, R.I. - (AP) The American subsidiary of a major British drug maker, GlaxoSmithKline LLC, has agreed to pay more than $40 million to 37 states and Washington, D.C., to settle complaints alleging manufacturing process issues at a now-shuttered... Read More

Tags: diabetes drug , drugs , SB Pharmco , health care , Food and Drug Administration , anti-nausea drug , Paxil , drug maker , Bactroban , Cidra , Medicaid , Avandamet , Litigation , GlaxoSmithKline , antibiotic , antidepressant , Puerto Rico , Kytril